Logo image of SG

SWEETGREEN INC - CLASS A (SG) Stock Fundamental Analysis

NYSE:SG - New York Stock Exchange, Inc. - US87043Q1085 - Common Stock - Currency: USD

32.9  +0.24 (+0.73%)

After market: 32.76 -0.14 (-0.43%)

Fundamental Rating

4

Taking everything into account, SG scores 4 out of 10 in our fundamental rating. SG was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. While SG has a great health rating, there are worries on its profitability. SG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SG had negative earnings in the past year.
SG had a positive operating cash flow in the past year.
SG had negative earnings in each of the past 5 years.
In the past 5 years SG reported 4 times negative operating cash flow.
SG Yearly Net Income VS EBIT VS OCF VS FCFSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of -10.34%, SG is doing worse than 88.55% of the companies in the same industry.
With a Return On Equity value of -19.16%, SG is not doing good in the industry: 61.83% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -10.34%
ROE -19.16%
ROIC N/A
ROA(3y)-18.09%
ROA(5y)-25%
ROE(3y)-27.38%
ROE(5y)-34.75%
ROIC(3y)N/A
ROIC(5y)N/A
SG Yearly ROA, ROE, ROICSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60

1.3 Margins

SG has a Gross Margin of 28.17%. This is amonst the worse of the industry: SG underperforms 80.15% of its industry peers.
In the last couple of years the Gross Margin of SG has declined.
The Profit Margin and Operating Margin are not available for SG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.07%
GM growth 5Y-3.64%
SG Yearly Profit, Operating, Gross MarginsSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

More info and screens

9

2. Health

2.1 Basic Checks

SG does not have a ROIC to compare to the WACC, probably because it is not profitable.
SG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SG has been reduced compared to 5 years ago.
SG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SG Yearly Shares OutstandingSG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
SG Yearly Total Debt VS Total AssetsSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

SG has an Altman-Z score of 5.01. This indicates that SG is financially healthy and has little risk of bankruptcy at the moment.
SG has a better Altman-Z score (5.01) than 87.79% of its industry peers.
SG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.01
ROIC/WACCN/A
WACC9.18%
SG Yearly LT Debt VS Equity VS FCFSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B

2.3 Liquidity

SG has a Current Ratio of 2.59. This indicates that SG is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.59, SG belongs to the best of the industry, outperforming 92.37% of the companies in the same industry.
A Quick Ratio of 2.57 indicates that SG has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.57, SG belongs to the best of the industry, outperforming 92.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.57
SG Yearly Current Assets VS Current LiabilitesSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.86% over the past year.
Looking at the last year, SG shows a very strong growth in Revenue. The Revenue has grown by 21.72%.
The Revenue has been growing by 21.51% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)31.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
Revenue 1Y (TTM)21.72%
Revenue growth 3Y38.34%
Revenue growth 5Y21.51%
Sales Q2Q%13.04%

3.2 Future

Based on estimates for the next years, SG will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.98% on average per year.
Based on estimates for the next years, SG will show a quite strong growth in Revenue. The Revenue will grow by 18.54% on average per year.
EPS Next Y17.64%
EPS Next 2Y22.6%
EPS Next 3Y17.95%
EPS Next 5Y16.98%
Revenue Next Year16.54%
Revenue Next 2Y16.64%
Revenue Next 3Y17.78%
Revenue Next 5Y18.54%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SG Yearly Revenue VS EstimatesSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
SG Yearly EPS VS EstimatesSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -2 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SG. In the last year negative earnings were reported.
Also next year SG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SG Price Earnings VS Forward Price EarningsSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SG Per share dataSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

SG's earnings are expected to grow with 17.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.6%
EPS Next 3Y17.95%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SWEETGREEN INC - CLASS A

NYSE:SG (2/4/2025, 8:07:20 PM)

After market: 32.76 -0.14 (-0.43%)

32.9

+0.24 (+0.73%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-26 2025-02-26/amc
Inst Owners93.73%
Inst Owner Change-0.26%
Ins Owners1.93%
Ins Owner Change-1%
Market Cap3.81B
Analysts80
Price Target42.13 (28.05%)
Short Float %15.22%
Short Ratio6.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.57%
Min EPS beat(2)-32.59%
Max EPS beat(2)-26.56%
EPS beat(4)1
Avg EPS beat(4)-20.66%
Min EPS beat(4)-32.59%
Max EPS beat(4)0.16%
EPS beat(8)2
Avg EPS beat(8)-14.83%
EPS beat(12)4
Avg EPS beat(12)-14.81%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.38%
Min Revenue beat(2)-3.91%
Max Revenue beat(2)-0.84%
Revenue beat(4)1
Avg Revenue beat(4)-1.55%
Min Revenue beat(4)-3.91%
Max Revenue beat(4)0.84%
Revenue beat(8)1
Avg Revenue beat(8)-3.31%
Revenue beat(12)2
Avg Revenue beat(12)-2.65%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.72%
PT rev (3m)4.82%
EPS NQ rev (1m)-8.04%
EPS NQ rev (3m)-17.87%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)-2.69%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.69
P/FCF N/A
P/OCF 82.39
P/B 8.21
P/tB 9.45
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.4
OCFY1.21%
SpS5.78
BVpS4.01
TBVpS3.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.34%
ROE -19.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.17%
FCFM N/A
ROA(3y)-18.09%
ROA(5y)-25%
ROE(3y)-27.38%
ROE(5y)-34.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.07%
GM growth 5Y-3.64%
F-Score6
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 120.2%
Cap/Sales 11.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 2.57
Altman-Z 5.01
F-Score6
WACC9.18%
ROIC/WACCN/A
Cap/Depr(3y)214.02%
Cap/Depr(5y)216.82%
Cap/Sales(3y)21.82%
Cap/Sales(5y)21.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
EPS Next Y17.64%
EPS Next 2Y22.6%
EPS Next 3Y17.95%
EPS Next 5Y16.98%
Revenue 1Y (TTM)21.72%
Revenue growth 3Y38.34%
Revenue growth 5Y21.51%
Sales Q2Q%13.04%
Revenue Next Year16.54%
Revenue Next 2Y16.64%
Revenue Next 3Y17.78%
Revenue Next 5Y18.54%
EBIT growth 1Y32.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year115.78%
EBIT Next 3Y37.29%
EBIT Next 5Y27.62%
FCF growth 1Y77.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y188.17%
OCF growth 3YN/A
OCF growth 5Y-24.51%